Positive Topline Results from the Phase 3 MonumenTAL-6 Trial: Teclistamab Plus Talquetamab, Talquetamab Plus Pomalidomide Improved PFS and OS vs Standard of Care in RRMM (https://www.myeloma.org/news-events/multiple-myeloma-news/phase-3-monumental-6-trial-results)

Source URL: https://www.myeloma.org/news-events/multiple-myeloma-news/phase-3-monumental-6-trial-results